SCHEMBL24738470

SCHEMBL24738470

Cc1cc(C)cc(-c2ccc3c(c2)c2cc(-c4cc(C)cc(C)c4)ccc2n3-c2cc(-c3cccc(C#N)c3)c(-n3c4ccc(-c5cc(C)cc(C)c5)cc4c4cc(-c5cc(C)cc(C)c5)ccc43)cn2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.39
PIK3CA P42336 1/20 0.39
KIT P10721 1/20 0.39
CYP1A2 P05177 6/20 0.38
CYP3A4 P08684 5/20 0.38
ALDH1A1 P00352 3/20 0.38
CLK4 Q9HAZ1 3/20 0.38
MAP4K4 O95819 1/20 0.38
GRM5 P41594 2/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
KMT2A Q03164 1/20 0.37
HIF1A Q16665 1/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 2/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21929183 0.96 NTRK1 (0.37) NTRK1PIK3CAKITCYP1A2CYP3A4
SCHEMBL21928977 0.95 CYP1A2 (0.41) NTRK1PIK3CAKITCYP1A2CYP3A4
SCHEMBL21929191 0.93 KIT (0.39) NTRK1PIK3CAKITCYP1A2CYP3A4
SCHEMBL21931689 0.93 MAP4K4 (0.43) NTRK1PIK3CAKITCYP1A2CYP3A4
SCHEMBL21929181 0.92 NTRK1 (0.37) NTRK1PIK3CAKITCYP1A2CYP3A4
SCHEMBL21931677 0.92 MAP4K4 (0.40) NTRK1PIK3CAKITCYP1A2CYP3A4
SCHEMBL23097980 0.91 CYP1A2 (0.37) NTRK1PIK3CAKITCYP1A2CYP3A4
SCHEMBL21928978 0.91 ELANE (0.40) NTRK1PIK3CAKITCYP1A2CYP3A4
SCHEMBL21929171 0.91 KIT (0.36) NTRK1PIK3CAKITCYP1A2CYP3A4
SCHEMBL20771046 0.89 CYP1A2 (0.40) NTRK1PIK3CACYP1A2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA NTRK1 3967/4885PIK3CA 4368/4885KIT 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.